<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">EMBO J</journal-id>
<journal-id journal-id-type="iso-abbrev">EMBO J</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1460-2075</journal-id>
<journal-id journal-id-type="publisher-id">EMBJ</journal-id>
<journal-id journal-id-type="hwp">embojnl</journal-id>
<journal-title-group>
<journal-title>The EMBO Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">0261-4189</issn>
<issn pub-type="epub">1460-2075</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31088843</article-id>
<article-id pub-id-type="pmc">6576196</article-id>
<article-id pub-id-type="doi">10.15252/embj.2018101033</article-id>
<article-id pub-id-type="publisher-id">EMBJ2018101033</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetic aberrations in human pluripotent stem cells</article-title>
<alt-title alt-title-type="left-running-head">Shiran Bar &amp; Nissim Benvenisty</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="embj2018101033-cr-0001">
<name>
<surname>Bar</surname>
<given-names>Shiran</given-names>
</name>
<xref ref-type="aff" rid="embj2018101033-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="embj2018101033-cr-0002">
<name>
<surname>Benvenisty</surname>
<given-names>Nissim</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8234-2685</contrib-id>
<address>
<email>nissimb@mail.huji.ac.il</email>
</address>
<xref ref-type="aff" rid="embj2018101033-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="embj2018101033-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Genetics</named-content>
<named-content content-type="organisation-division">The Azrieli Center for Stem Cells and Genetic Research</named-content>
<named-content content-type="organisation-division">Silberman Institute of Life Sciences</named-content>
<institution>The Hebrew University</institution>
<named-content content-type="city">Jerusalem</named-content>
<country country="IL">Israel</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>Corresponding author. Tel: +972 2 6586774; E‐mail: <email>nissimb@mail.huji.ac.il</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>14</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>17</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>38</volume>
<issue>12</issue>
<issue-id pub-id-type="doi">10.1002/embj.v38.12</issue-id>
<elocation-id>e101033</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>13</day>
<month>3</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2019 EMBO <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:EMBJ-38-e101033.pdf" xlink:type="simple"></self-uri>
<abstract id="embj2018101033-abs-0001">
<title>Abstract</title>
<p>Human pluripotent stem cells (hPSCs) are being increasingly utilized worldwide in investigating human development, and modeling and discovering therapies for a wide range of diseases as well as a source for cellular therapy. Yet, since the first isolation of human embryonic stem cells (hESCs) 20 years ago, followed by the successful reprogramming of human‐induced pluripotent stem cells (hiPSCs) 10 years later, various studies shed light on abnormalities that sometimes accumulate in these cells <italic>in vitro</italic>. Whereas genetic aberrations are well documented, epigenetic alterations are not as thoroughly discussed. In this review, we highlight frequent epigenetic aberrations found in hPSCs, including alterations in DNA methylation patterns, parental imprinting, and X chromosome inactivation. We discuss the potential origins of these abnormalities in hESCs and hiPSCs, survey the different methods for detecting them, and elaborate on their potential consequences for the different utilities of hPSCs.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="embj2018101033-kwd-0001">DNA methylation</kwd>
<kwd id="embj2018101033-kwd-0002">epigenetic alterations</kwd>
<kwd id="embj2018101033-kwd-0003">human pluripotent stem cells</kwd>
<kwd id="embj2018101033-kwd-0004">imprinting</kwd>
<kwd id="embj2018101033-kwd-0005">X chromosome inactivation</kwd>
</kwd-group>
<kwd-group kwd-group-type="subject-categories">
<title>Subject Categories</title>
<kwd>Chromatin, Epigenetics, Genomics &amp; Functional Genomics</kwd>
<kwd>Development &amp; Differentiation</kwd>
<kwd>Stem Cells</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>US–Israel Binational Science Foundation</funding-source>
<award-id>2015089</award-id>
</award-group>
<award-group>
<funding-source>Israel Science Foundation</funding-source>
<award-id>494/17</award-id>
</award-group>
<award-group>
<funding-source>Azrieli Foundation</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="1"></table-count>
<page-count count="18"></page-count>
<word-count count="16550"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>embj2018101033</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>17 June 2019</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.4 mode:remove_FC converted:17.06.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="embj2018101033-cit-1001" publication-type="journal">
<source xml:lang="en"/>The EMBO Journal (<year>2019</year>) <volume>38</volume>: <elocation-id>e101033</elocation-id>
</mixed-citation>
</p>
</notes>
</front>
</article>
</pmc-articleset>